Celera Healthcare Private Limited logo

Celera Healthcare Private Limited

Pharmaceutical company specializing in orthopedics, gynecology, and medicine.
2014 | Ghaziabad, Uttar Pradesh (India) | Active

Last Updated:

June 19, 2024
HomeCompanyCelera Healthcare Private Limited

Who are the key members and board of directors at Celera Healthcare?

Board Members(2)

NameDesignationAppointment DateStatus
Deepak Bakshi In Director 21-Mar-2016Current
Neeraj Saxena In Director 29-Aug-2014Current

Financial Performance of Celera Healthcare.

Celera Healthcare Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 21.33% decrease. The company also saw a substantial fall in profitability, with a 44.69% decrease in profit. The company's net worth moved up by a moderate rise of 9.78%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-21.33%
Revenue from Operations
-21.28%
Total Assets
2.96%
Profit or Loss
-44.69%
Net Worth
9.78%
EBITDA
1.55%

Charges (Loans)

Open Charges

₹4.00 M

LenderAmountStatus

Canara Bank

Creation Date: 15 Sep 2022
₹2.50 MOpen

Canara Bank

Creation Date: 14 Jul 2020
₹1.50 MOpen

How Many Employees Work at Celera Healthcare?

Unlock and access historical data on people associated with Celera Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Celera Healthcare

Recent activity within the organization

  • Annual General Meeting

    Celera Healthcare Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Celera Healthcare Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kanpur.

    31 Mar 2023

  • Charges

    A charge with Canara Bank amounted to Rs. 2.50 M with Charge ID 100630179 was registered on 15 Sep 2022.

    15 Sep 2022

  • Charges

    A charge with Canara Bank amounted to Rs. 1.50 M with Charge ID 100357085 was registered on 14 Jul 2020.

    14 Jul 2020

  • Director Appointment

    Deepak Bakshi was appointed as a Director was appointed as a Director on 21 Mar 2016 & has been associated with this company since 8 years 9 months .

    21 Mar 2016

  • Director Appointment

    Neeraj Saxena was appointed as a Director was appointed as a Director on 29 Aug 2014 & has been associated with this company since 10 years 3 months .

    29 Aug 2014

Frequently asked questions

  • Celera Healthcare Private Limited was incorporated on 29 Aug 2014.

  • The authorized share capital of Celera Healthcare Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.

  • Currently 2 directors are associated with Celera Healthcare Private Limited.

    • Neeraj Saxena
    • Deepak Bakshi
  • As per Ministry of Corporate Affairs (Mca), the registered address of Celera Healthcare Private Limited is Gyan Khand-I 61/ Ff B-1Indirapuram, Ghaziabad, Uttar Pradesh, India, 201010.

  • The corporate identification number (CIN) of Celera Healthcare Private Limited is U74120UP2014PTC065750 and the company number is 065750 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Celera Healthcare Private Limited is https://www.celerahealthcare.com

  • According to the financial reports for the fiscal year 2021, the revenue trend for Celera Healthcare Private Limited has fallen by -21.33%.

  • The financial reports for the fiscal year 2021 indicates that The net worth of Celera Healthcare Private Limited has experienced an upsurge of 9.78%.

  • As per the financial statements for fiscal Year 2021, The total open charges for Celera Healthcare Private Limited amount to ₹ 4.00 M.

  • The most recent Balance Sheet for Celera Healthcare Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development